WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2010144446) (S) -2-BENZYL-3- ( (3R, 4R) -4- (3 -CARBAMO YLPHENYL) -3, 4-DIMETHYLPIPERIDINYL) PROPANOIC ACID AND SALT THEROF AS ANTAGONISTS OF THE OPIOID RECEPTORS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2010/144446    International Application No.:    PCT/US2010/037772
Publication Date: 16.12.2010 International Filing Date: 08.06.2010
IPC:
C07D 211/34 (2006.01), A61K 31/451 (2006.01), A61P 1/00 (2006.01), A61P 25/04 (2006.01)
Applicants: ADOLOR CORPORATION [US/US]; 700 Pennsylvania Avenue Exton, PA 19341 (US) (For All Designated States Except US).
DOLLE, Roland, E. [US/US]; (US) (For US Only).
LE BOURDONNEC, Bertrand [US/US]; (US) (For US Only)
Inventors: DOLLE, Roland, E.; (US).
LE BOURDONNEC, Bertrand; (US)
Agent: FRANK, Walter C.; Feldman Gale, P.A. 1700 Market Street, Suite 3130 Philadelphia, PA 19103 (US)
Priority Data:
12/795,095 07.06.2010 US
61/184,891 08.06.2009 US
Title (EN) (S) -2-BENZYL-3- ( (3R, 4R) -4- (3 -CARBAMO YLPHENYL) -3, 4-DIMETHYLPIPERIDINYL) PROPANOIC ACID AND SALT THEROF AS ANTAGONISTS OF THE OPIOID RECEPTORS
(FR) ACIDE (S)-2-BENZYL-3-((3R, 4R)-4-(3-CARBAMOYLPHÉNYLE)-3,4-DIMÉTHYLPIPÉRIDINYLE) PROPANOÏQUE ET SON SEL EN TANT QU'ANTAGONISTES DES RÉCEPTEURS OPIOÏDES
Abstract: front page image
(EN)Novel 3,4-disubstituted-4-(3-carbamoylphenyl)-piperidinylpropanoic acid compounds and their salts, including pharmaceutically acceptable salts, pharmaceutical compositions and methods of their use are disclosed. The novel compounds are useful, inter alia, as antagonists of opioid receptors.
(FR)La présente invention a pour objet de nouveaux composés de l'acide 3,4-disubstitué-4-(3-carbamoylphényle)-pipéridinylpropanoïque et leurs sels, comprenant des sels pharmaceutiquement acceptables, des compositions pharmaceutiques et leurs procédés d'utilisation. Les nouveaux composés sont utiles, entre autres, en tant qu'antagonistes des récepteurs opioïdes.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)